ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
MercachemSyncom, a Dutch contract development and manufacturing organization (CDMO), has acquired Admescope, a specialist in pharmaceutical absorption, distribution, metabolism, and excretion studies. Admescope, with dual headquarters in Finland and Sweden, employs about 40 scientists with expertise in drug metabolism, drug interactions, pharmacokinetics, and quantitative bioanalysis. Earlier this year, Mercachem acquired a pharmaceutical chemical development site in Weert, the Netherlands, from the US CDMO Alcami.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter